Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Molecular combing compared to Southern blot for measuring D4Z4 contractions in FSHD.

Vasale J, Boyar F, Jocson M, Sulcova V, Chan P, Liaquat K, Hoffman C, Meservey M, Chang I, Tsao D, Hensley K, Liu Y, Owen R, Braastad C, Sun W, Walrafen P, Komatsu J, Wang JC, Bensimon A, Anguiano A, Jaremko M, Wang Z, Batish S, Strom C, Higgins J.

Neuromuscul Disord. 2015 Dec;25(12):945-51. doi: 10.1016/j.nmd.2015.08.008. Epub 2015 Aug 21.

PMID:
26420234
2.

Genomic integration of lambda EG10 transgene in gpt delta transgenic rodents.

Masumura K, Sakamoto Y, Kumita W, Honma M, Nishikawa A, Nohmi T.

Genes Environ. 2015 Dec 1;37:24. doi: 10.1186/s41021-015-0024-6. eCollection 2015.

3.

Genotype-phenotype analysis of recombinant chromosome 4 syndrome: an array-CGH study and literature review.

Hemmat M, Hemmat O, Anguiano A, Boyar FZ, El Naggar M, Wang JC, Wang BT, Sahoo T, Owen R, Haddadin M.

Mol Cytogenet. 2013 May 2;6(1):17. doi: 10.1186/1755-8166-6-17.

4.

Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.

Driessen EM, van Roon EH, Spijkers-Hagelstein JA, Schneider P, de Lorenzo P, Valsecchi MG, Pieters R, Stam RW.

Haematologica. 2013 Jun;98(6):937-44. doi: 10.3324/haematol.2012.067983. Epub 2013 Feb 12.

5.

Chromosome replicating timing combined with fluorescent in situ hybridization.

Smith L, Thayer M.

J Vis Exp. 2012 Dec 10;(70):e4400. doi: 10.3791/4400.

6.

Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes.

Urbankova H, Baens M, Michaux L, Tousseyn T, Rack K, Katrincsakova B, Ferreiro JF, van Loo P, de Kelver W, Dierickx D, Demuynck H, Delannoy A, Verschuere J, Jarošová M, de Wolf-Peeters C, Vandenberghe P, Wlodarska I.

Leuk Lymphoma. 2012 Dec;53(12):2449-55. doi: 10.3109/10428194.2012.690098.

PMID:
22553924
7.

Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.

Stumpel DJ, Schneider P, Seslija L, Osaki H, Williams O, Pieters R, Stam RW.

Leukemia. 2012 Apr;26(4):682-92. doi: 10.1038/leu.2011.278. Epub 2011 Oct 21.

PMID:
22015773
8.

High-resolution chromosome painting reveals the first genetic signature for the chiropteran suborder Pteropodiformes (Mammalia: Chiroptera).

Volleth M, Yang F, Müller S.

Chromosome Res. 2011 May;19(4):507-19. doi: 10.1007/s10577-011-9196-5. Epub 2011 Mar 11.

PMID:
21394511
9.

Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale.

Stumpel DJ, Schotte D, Lange-Turenhout EA, Schneider P, Seslija L, de Menezes RX, Marquez VE, Pieters R, den Boer ML, Stam RW.

Leukemia. 2011 Mar;25(3):429-39. doi: 10.1038/leu.2010.282. Epub 2010 Nov 30.

PMID:
21116279
10.

MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.

Juszczynski P, Rodig SJ, Ouyang J, O'Donnell E, Takeyama K, Mlynarski W, Mycko K, Szczepanski T, Gaworczyk A, Krivtsov A, Faber J, Sinha AU, Rabinovich GA, Armstrong SA, Kutok JL, Shipp MA.

Clin Cancer Res. 2010 Apr 1;16(7):2122-30. doi: 10.1158/1078-0432.CCR-09-2765. Epub 2010 Mar 23.

11.

NF-kappaB activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemia.

Tracey L, Streck CJ, Du Z, Williams RF, Pfeffer LM, Nathwani AC, Davidoff AM.

Leukemia. 2010 Apr;24(4):806-12. doi: 10.1038/leu.2010.2. Epub 2010 Feb 4.

12.

Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.

Stumpel DJ, Schneider P, van Roon EH, Boer JM, de Lorenzo P, Valsecchi MG, de Menezes RX, Pieters R, Stam RW.

Blood. 2009 Dec 24;114(27):5490-8. doi: 10.1182/blood-2009-06-227660. Epub 2009 Oct 23.

13.

A Pol V-mediated silencing, independent of RNA-directed DNA methylation, applies to 5S rDNA.

Douet J, Tutois S, Tourmente S.

PLoS Genet. 2009 Oct;5(10):e1000690. doi: 10.1371/journal.pgen.1000690. Epub 2009 Oct 16.

14.

Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents.

Bennett CA, Winters AC, Barretto NN, Hemenway CS.

Leuk Res. 2009 Jul;33(7):937-47. doi: 10.1016/j.leukres.2009.01.018. Epub 2009 Feb 20.

15.

Differential expression of Ikaros isoforms in monozygotic twins with MLL-rearranged precursor-B acute lymphoblastic leukemia.

Russell T, Oliver JM, Wilson BS, Tarleton CA, Winter SS, Meng X.

J Pediatr Hematol Oncol. 2008 Dec;30(12):941-4. doi: 10.1097/MPH.0b013e318180bbf5.

PMID:
19131787
16.

On the association between chromosomal rearrangements and genic evolution in humans and chimpanzees.

Marques-Bonet T, Sànchez-Ruiz J, Armengol L, Khaja R, Bertranpetit J, Lopez-Bigas N, Rocchi M, Gazave E, Navarro A.

Genome Biol. 2007;8(10):R230.

17.

KIT gene in pediatric osteosarcomas: could it be a new therapeutic target?

Entz-Werle N, Gaub MP, Lavaux T, Marcellin L, Metzger N, Marec-Berard P, Schmitt C, Brugiere L, Kalifa C, Tabone MD, Pacquement H, Gentet P, Lutz P, Oudet P, Babin A.

Int J Cancer. 2007 Jun 1;120(11):2510-6.

18.

Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?

Mann G, Cazzaniga G, van der Velden VH, Flohr T, Csinady E, Paganin M, Schrauder A, Dohnal AM, Schrappe M, Biondi A, Gadner H, van Dongen JJ, Panzer-Grümayer ER.

Leukemia. 2007 Apr;21(4):642-6. Epub 2007 Feb 8.

PMID:
17287854
19.

Two consecutive immunophenotypic switches in a child with MLL-rearranged acute lymphoblastic leukemia.

Germano G, Pigazzi M, del Giudice L, Campo Dell'Orto M, Spinelli M, Zangrando A, Paolucci P, Ladogana S, Basso G.

Haematologica. 2006 May;91(5 Suppl):ECR09.

20.

Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).

Neudenberger J, Hotfilder M, Rosemann A, Langebrake C, Reinhardt D, Pieters R, Schrauder A, Schrappe M, Röttgers S, Harbott J, Vormoor J.

Br J Haematol. 2006 May;133(3):337-44.

PMID:
16643437

Supplemental Content

Loading ...
Support Center